List of Certificates of Suitability (CEPs) for r1_cep_2009_023___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Question

Looking for Certificates of Suitability (CEPs) for R1-CEP 2009-023 - Rev 02 of Megafine Pharma (p) Limited Mumbai In

score 20 · Accepted Answer

Megafine Pharma (p) Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Megafine Pharma is engaged in the production of APIs, and advanced intermediates, and offers contract manufacturing services.

One of their significant offerings is Venlafaxine hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2009-023 - Rev 02

This Chemical Type CEP, issued on June 13, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 2119 associated with this CEP further emphasizes

List of Certificates of Suitability (CEPs) for r1_cep_2009_023___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Megafine Pharma (P) Limited

VISIT THE VIRTUAL BOOTH

Review portfolio & marketing content

CONTACT DETAILS

Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

PRESENTATION(s)

DIGITAL CONTENT

4 CORPORATE CONTENT #SupplierSpotlight

1 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

KEY PRODUCTS

INSPECTIONS & REGISTRATIONS

Filters

R1-CEP 2009-023 - Rev 02

Valid

Chemical

2022-06-13

2119

01

Looking for Certificates of Suitability (CEPs) for R1-CEP 2009-023 - Rev 02 of Megafine Pharma (p) Limited Mumbai In